The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Open accessAbstract
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute leukemias, largely derived from gene expression analysis and next-generation sequencing that can significantly improve the diagnostic criteria as well as the prognostic relevance of entities currently included in the WHO classification and that also suggest new entities that should be added. Therefore, there is a clear need for a revision to the current classification. The revisions to the categories of myeloid neoplasms and acute leukemia will be published in a monograph in 2016 and reflect a consensus of opinion of hematopathologists, hematologists, oncologists, and geneticists. The 2016 edition represents a revision of the prior classification rather than an entirely new classification and attempts to incorporate new clinical, prognostic, morphologic, immunophenotypic, and genetic data that have emerged since the last edition. The major changes in the classification and their rationale are presented here.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
EPI-CT evaluated risk using the revised World Health Organization classification of hematopoietic and lymphoid tissue malignancies.
“EPI-CT also evaluated risk using the revised World Health Organization (WHO) classification of hematopoietic and lymphoid tissue malignancies27,28.”
From Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults (2023) · cites this paper as [27]
For CML patients, disease diagnosis and progression were defined according to the 2016 edition of World Health Organization criteria.
“For CML patients, disease diagnosis and progression were defined according to the 2016 edition of World Health Organization criteria.75”
From Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia (2024) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Part of this paper’s reference list could not be split into single entries.
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078 · see citing works
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · see citing works
Vardiman, J., Thiele, J., Arber, D., Brunning, R., Borowitz, M., Porwit, A., Harris, N., Beau, M. L. L., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,837 · see citing works
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531 · see citing works
Döhner, H., Weisdorf, D. J., & Bloomfield, C. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1406184 · Cited by 3,354 · see citing works
Self-citationRevised International Prognostic Scoring System for Myelodysplastic Syndromes
Greenberg, P. L., Tuechler, H., Schanz, J., Sanz, G. F., Garcia‐Manero, G., Solé, F. G., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., et al. (2012) · Blood · doi:10.1182/blood-2012-03-420489 · Cited by 3,181 · see citing works
Self-citationEuropean LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M., Deininger, M. W., Rosti, G., Hochhaus, A., Soverini, S., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Guilhot, F., et al. (2013) · Blood · doi:10.1182/blood-2013-05-501569 · Cited by 1,985 · see citing works
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971 · see citing works
Self-citationPrognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H. F., Sun, Z., Racevskis, J., Vlierberghe, P. V., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,936 · see citing works
Grimwade, D. J., Hills, R. K., Moorman, A. V., Walker, H., Chatters, S., Goldstone, A. H., Wheatley, K., Harrison, C. J., & Burnett, A. K. (2010) · Blood · doi:10.1182/blood-2009-11-254441 · Cited by 1,936 · see citing works
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832 · see citing works
Self-citationClinical Effect of Point Mutations in Myelodysplastic Syndromes
Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., Kantarjian, H., Raza, A., Levine, R. L., Neuberg, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013343 · Cited by 1,627 · see citing works
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596 · cited 1× · see citing works
“Myeloidassociated gene mutations, such as FLT3, NRAS/KRAS, DNMT3A, IDH1, and IDH2, are reported at high frequency in ETP ALL,(129,130) whereas more typical T-ALL–associated mutations such as activating mutations in NOTCH1 or mutations in CDKN1/2 are infrequent.(131) Although initial small series of ETP ALL suggested t…”
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T., Nagata, Y., Grossmann, V, Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014) · Leukemia · doi:10.1038/leu.2013.336 · Cited by 1,532 · see citing works
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422 · see citing works
Self-citationTargetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Roberts, K. G., Li, Y., Payne-Turner, D., Harvey, R. C., Yang, Y., Pei, D., McCastlain, K., Ding, L., Lu, C. S., Song, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403088 · Cited by 1,369 · see citing works
Self-citationSomatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222 · see citing works
Self-citationDiagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Núñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,107 · see citing works
Self-citationEarly T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan‐Smith, E., Mullighan, C. G., Onciu, M. M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,012 · see citing works
den Boer, M. L., van Slegtenhorst, M., de Menezes, R. X., Cheok, M. H.-C., Buijs-Gladdines, J. G. C. A. M., Peters, S. T. C. J. M., van Zutven, L. J. C. M., Beverloo, H. B., van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 927 · see citing works
Tefferi, A., Guglielmelli, P., Larson, D. R., Finke, C. M., Wassie, E. A., Pieri, L., Gangat, N., Fjerza, R., Belachew, A. A., Lasho, T. L., et al. (2014) · Blood · doi:10.1182/blood-2014-05-579136 · Cited by 748 · see citing works
Self-citationThe genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Díaz-Flores, E., Walsh, M. F., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M. L., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 722 · see citing works
Self-citationRoberts, K. G., Morin, R. D., Zhang, J., Hirst, M., Zhao, Y., Su, X., Chen, S.-C., Payne-Turner, D., Churchman, M. L., Harvey, R. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.005 · Cited by 706 · see citing works
Schanz, J., Tüchler, H., Solé, F. G., Mallo, M., Luño, E., Cervera, J., Granada, I., Hildebrandt, B., Slovak, M. L., Ohyashiki, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6394 · Cited by 688 · see citing works
A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia
Gröschel, S., Sanders, M. A., Hoogenboezem, R., de Wit, E., Bouwman, B. A. M., Erpelinck, C., van der Velden, V. H. J., Havermans, M., Avellino, R., van Lom, K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.019 · Cited by 687 · see citing works
Harvey, R. C., Mullighan, C. G., Chen, I., Wharton, W., Mikhail, F. M., Carroll, A. J., Kang, H., Liu, W., Dobbin, K. K., Smith, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245944 · Cited by 568 · see citing works
Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Maxson, J. E., Gotlib, J., Pollyea, D., Fleischman, A. G., Agarwal, A., Eide, C., Bottomly, D., Wilmot, B., McWeeney, S., Tognon, C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214514 · Cited by 568 · see citing works
Wouters, B. J., Löwenberg, B., Erpelinck-Verschueren, C. A. J., van Putten, W. L. J., Valk, P. J. M., & Delwel, R. (2009) · Blood · doi:10.1182/blood-2008-09-179895 · Cited by 566 · see citing works
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Itzykson, R., Kosmider, O., Renneville, A., Gelsi‐Boyer, V., Meggendorfer, M., Morabito, M., Berthon, C., Adès, L., Fenaux, P., Beyne‐Rauzy, O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3314 · Cited by 546 · see citing works
Barbui, T., Thiele, J., Passamonti, F., Rumi, E., Boveri, E., Ruggeri, M., Rodeghiero, F., dʼAmore, E. S. G., Randi, M. L., Bertozzi, I., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.5298 · Cited by 534 · see citing works
Self-citationMalcovati, L., Papaemmanuil, E., Bowen, D., Boultwood, J., Porta, M. G. D., Pascutto, C., Travaglino, E., Groves, M. J., Godfrey, A. L., Ambaglio, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377275 · Cited by 496 · see citing works
Self-citation<i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
Jädersten, M., Saft, L., Smith, A., Kulasekararaj, A., Pomplun, S., Göhring, G., Hedlund, A., Hast, R., Schlegelberger, B., Porwit, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.8576 · Cited by 463 · see citing works
Gaidzik, V. I., Bullinger, L., Schlenk, R. F., Zimmermann, A., Röck, J., Paschka, P., Corbacioglu, A., Krauter, J., Schlegelberger, B., Ganser, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7926 · Cited by 454 · see citing works
Bejar, R. L., Stevenson, K. E., Caughey, B. A., Abdel-Wahab, O. I., Steensma, D. P., Galili, N., Raza, A., Kantarjian, H. M., Levine, R. L., Neuberg, D. S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7379 · Cited by 442 · see citing works
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jädersten, M., Jansson, M., Elena, C., Gallì, A., Walldin, G., Della Porta, M. G., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633537 · Cited by 434 · see citing works
Self-citationNiemeyer, C. M., Aricò, M., Basso, G., Biondi, A., Rajnoldi, A. C., Creutzig, U., Haas, O. A., Harbott, J., Hasle, H., Kerndrup, G. B., et al. (1997) · PubMed · doi:10.1182/blood.v89.10.3534 · Cited by 405 · see citing works
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Piazza, R., Valletta, S., Winkelmann, N., Redaelli, S., Spinelli, R., Pirola, A., Antolini, L., Mologni, L., Donadoni, C., Papaemmanuil, E., et al. (2012) · Nature Genetics · doi:10.1038/ng.2495 · Cited by 396 · see citing works
Bejar, R. L., Stevenson, K. E., Caughey, B. A., Lindsley, R. C., Mar, B. G., Stojanov, P., Getz, G. A., Steensma, D. P., Ritz, J., Soiffer, R. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.3381 · Cited by 396 · see citing works
The landscape of somatic mutations in Down syndrome–related myeloid disorders
Yoshida, K., Toki, T., Okuno, Y., Kanezaki, R., Shiraishi, Y., Sato‐Otsubo, A., Sanada, M., Park, M.-J., Terui, K., Suzuki, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2759 · Cited by 377 · see citing works
Tang, J., Hou, H., Chen, C., Liu, C., Chou, W., Tseng, M., Huang, C., Lee, F., Liu, M.-C., Yao, M., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223784 · Cited by 343 · see citing works
Gisslinger, H., Gotić, M., Hołowiecki, J., Penka, M., Thiele, J., Kvasnicka, H. M., Královics, R., & Petrides, P. E. (2013) · Blood · doi:10.1182/blood-2012-07-443770 · Cited by 328 · see citing works
Self-citationMatutes, E., Pickl, W. F., Veer, M. B. V., Morilla, R. M., Swansbury, J. G., Strobl, H., Attarbaschi, A., Hopfinger, G., Ashley, S., Béné, M. C., et al. (2011) · Blood · doi:10.1182/blood-2010-10-314682 · Cited by 325 · see citing works
Kwok, B., Hall, J., Witte, J. S., Xu, Y., Reddy, P., Lin, K., Flamholz, R., Dabbas, B., Yung, A., Al-Hafidh, J., et al. (2015) · Blood · doi:10.1182/blood-2015-08-667063 · Cited by 317 · see citing works
Lange, B. J., Kobrinsky, N. L., Barnard, D., Arthur, D. C., Buckley, J. D., Howells, W. B., Gold, S., Sanders, J. E., Neudorf, S. M. L., Smith, F. O., et al. (1998) · PubMed · doi:10.1182/blood.v91.2.608 · Cited by 303 · see citing works
Green, C. L., Koo, K., Hills, R. K., Burnett, A. K., Linch, D. C., & Gale, R. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2501 · Cited by 273 · see citing works
Mendler, J. H., Maharry, K. S., Radmacher, M. D., Mrózek, K., Becker, H., Metzeler, K. H., Schwind, S., Whitman, S. P., Khalife, J., Kohlschmidt, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.6652 · Cited by 268 · see citing works
Self-citationSchnittger, S., Dicker, F., Kern, W., Wendland, N., Sundermann, J., Alpermann, T., Haferlach, C., & Haferlach, T. (2010) · Blood · doi:10.1182/blood-2009-11-255976 · Cited by 265 · see citing works
Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system
Passmore, S. J., Hann, I. M., Stiller, C. A., Ramani, P., Swansbury, G. J., Gibbons, B., Reeves, B. R., & Chessells, J. M. (1995) · Blood · doi:10.1182/blood.v85.7.1742.bloodjournal8571742 · Cited by 244 · see citing works
Gerstung, M., Pellagatti, A., Malcovati, L., Giagounidis, A. A. N., Porta, M. G. D., Jädersten, M., Dolatshad, H., Verma, A. K., Cross, N. C. P., Vyas, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms6901 · Cited by 238 · see citing works
Self-citationYamazaki, H., Suzuki, M., Otsuki, A., Shimizu, R., Bresnick, E. H., Engel, J. D., & Yamamoto, M. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.008 · Cited by 237 · see citing works
How I treat juvenile myelomonocytic leukemia
Locatelli, F., & Niemeyer, C. M. (2015) · Blood · doi:10.1182/blood-2014-08-550483 · Cited by 234 · see citing works
Patrick, K., Wade, R. L., Goulden, N. J., Mitchell, C., Moorman, A. V., Rowntree, C. J., Jenkinson, S., Hough, R. E., & Vora, A. J. (2014) · British Journal of Haematology · doi:10.1111/bjh.12882 · Cited by 233 · see citing works
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations
Neumann, M., Heesch, S., Schlee, C., Schwartz, S., Gökbuget, N., Hoelzer, D. F., Konstandin, N. P., Ksienzyk, B., Vosberg, S., Graf, A., et al. (2013) · Blood · doi:10.1182/blood-2012-11-465138 · Cited by 216 · see citing works
Tefferi, A., Thiele, J., Vannucchi, A. M., & Barbui, T. (2014) · Leukemia · doi:10.1038/leu.2014.35 · Cited by 216 · see citing works
Self-citationWeston, B. W., Hayden, M. A., Roberts, K. G., Bowyer, S., Hsu, J. H., Fedoriw, Y. D., Rao, K. W., & Mullighan, C. G. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.6770 · Cited by 212 · see citing works
Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
Jabbour, E. J., & Kantarjian, H. M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23691 · Cited by 212 · see citing works
Wang, S. A., Hasserjian, R. P., Fox, P. S., Rogers, H. J., Geyer, J. T., Chabot‐Richards, D., Weinzierl, E. P., Hatem, J., Jaso, J. M., Kanagal‐Shamanna, R., et al. (2014) · Blood · doi:10.1182/blood-2014-02-553800 · Cited by 205 · see citing works
Self-citationHarrison, C. J., Moorman, A. V., Schwab, C. J., Carroll, A. J., Raetz, E. A., Devidas, M., Strehl, S., Nebral, K., Harbott, J., Teigler‐Schlegel, A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.317 · Cited by 203 · see citing works
Philadelphia Chromosome–Positive Acute Myeloid Leukemia
Soupir, C. P., Vergilio, J., Cin, P. D., Muzikansky, A., Kantarjian, H. M., Jones, D. M., & Hasserjian, R. P. (2007) · American Journal of Clinical Pathology · doi:10.1309/b4nver1ajj84ctuu · Cited by 193 · see citing works
Self-citationThiele, J., Kvasnicka, H. M., Müllauer, L., Buxhofer‐Ausch, V., Gisslinger, B., & Gisslinger, H. (2011) · Blood · doi:10.1182/blood-2010-07-293761 · Cited by 182 · see citing works
Self-citationMeggendorfer, M., Bacher, U., Alpermann, T., Haferlach, C., Kern, W., Gambacorti-Passerini, C. B., Haferlach, T., & Schnittger, S. (2013) · Leukemia · doi:10.1038/leu.2013.133 · Cited by 181 · see citing works
Orazi, A., & Germing, U. (2008) · Leukemia · doi:10.1038/leu.2008.119 · Cited by 178 · see citing works
Self-citationTargeted sequencing identifies patients with preclinical MDS at high risk of disease progression
Cargo, C. A., Rowbotham, N. J., Evans, P., Barrans, S., Bowen, D., Crouch, S., & Jack, A. (2015) · Blood · doi:10.1182/blood-2015-08-663237 · Cited by 178 · see citing works
Churpek, J. E., Marquez, R., Neistadt, B., Claussen, K., Lee, M. K., Churpek, M. M., Huo, D., Weiner, H., Banerjee, M., Godley, L. A., et al. (2015) · Cancer · doi:10.1002/cncr.29615 · Cited by 170 · see citing works
Haferlach, C., Mecucci, C., Schnittger, S., Kohlmann, A., Mancini, M., Cuneo, A., Testoni, N., Rege‐Cambrin, G., Santucci, A., Vignetti, M., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197871 · Cited by 167 · see citing works
Weinberg, O. K., Seetharam, M., Ren, L., Seo, K., Ma, L., Merker, J. D., Gotlib, J. R., Zehnder, J. L., & Arber, D. A. (2009) · Blood · doi:10.1182/blood-2008-10-182782 · Cited by 165 · see citing works
Self-citationInukai, T., Kiyokawa, N., Campana, D., Coustan‐Smith, E., Kikuchi, A., Kobayashi, M., Takahashi, H., Koh, K., Manabe, A., Kumagai, M., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08955.x · Cited by 162 · see citing works
Granulocytic sarcoma: a systematic review.
Yılmaz, A. F., Saydam, G., Şahin, F., & Baran, Y. (2013) · Europe PMC (PubMed Central) · Cited by 161 · see citing works
Pabst, T., Eyholzer, M., Fos, J., & Mueller, B. U. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604977 · Cited by 157 · see citing works
Schlenk, R. F., Taskesen, E., van Norden, Y., Krauter, J., Ganser, A., Bullinger, L., Gaidzik, V. I., Paschka, P., Corbacioglu, A., Göhring, G., et al. (2013) · Blood · doi:10.1182/blood-2013-05-503847 · Cited by 154 · see citing works
Masked polycythemia Vera (mPV): Results of an international study
Barbui, T., Thiele, J., Gisslinger, H., Finazzi, G., Carobbio, A., Rumi, E., Randi, M. L., Betozzi, I., Vannucchi, A. M., Pieri, L., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23585 · Cited by 151 · see citing works
Self-citationBiologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms
Cazzola, M., Rossi, M., & Malcovati, L. (2012) · Blood · doi:10.1182/blood-2012-09-399725 · Cited by 151 · see citing works
Self-citationWood, B. L., Winter, S. S., Dunsmore, K. P., Devidas, M., Chen, S., Asselin, B. L., Esiashvili, N., Loh, M. L., Winick, N. J., Carroll, W. L., et al. (2014) · Blood · doi:10.1182/blood.v124.21.1.1 · Cited by 147 · see citing works
Chronic myelomonocytic leukemia
Bennett, J. M. (2002) · Current Treatment Options in Oncology · doi:10.1007/s11864-002-0011-6 · Cited by 146 · see citing works
Walter, R. B., Othus, M. K. D., Burnett, A. K., Löwenberg, B., Kantarjian, H. M., Ossenkoppele, G. J., Hills, R. K., van Montfort, K., Ravandi, F., Evans, A., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462440 · Cited by 146 · see citing works
Porta, M. G. D., Travaglino, E., Boveri, E., Ponzoni, M., Malcovati, L., Papaemmanuil, E., Rigolin, G. M., Pascutto, C., Croci, G. A., Gianelli, U., et al. (2014) · Leukemia · doi:10.1038/leu.2014.161 · Cited by 145 · see citing works
Self-citationRicci, C., Fermo, E., Corti, S. P., Molteni, M., Faricciotti, A., Cortelezzi, A., Deliliers, G. L., Beran, M., & Onida, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2112 · Cited by 141 · see citing works
Saft, L., Karimi, M., Ghaderi, M., Matolcsy, A., Mufti, G. J., Kulasekararaj, A. G., Göhring, G., Giagounidis, A. A. N., Selleslag, D., Muus, P., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.098103 · Cited by 137 · see citing works
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
Patnaik, M. M., & Tefferi, A. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.5 · Cited by 137 · see citing works
Heerema, N. A., Carroll, A. J., Devidas, M., Loh, M. L., Borowitz, M. J., Gastier, J. M., Larsen, E. C., Mattano, L. A., Maloney, K. W., Willman, C. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1308 · Cited by 136 · see citing works
Self-citationRecurrent ETNK1 mutations in atypical chronic myeloid leukemia
Gambacorti-Passerini, C. B., Donadoni, C., Parmiani, A., Pirola, A., Redaelli, S., Signore, G., Piazza, V., Malcovati, L., Fontana, D., Spinelli, R., et al. (2014) · Blood · doi:10.1182/blood-2014-06-579466 · Cited by 129 · see citing works
Self-citationBarbui, T., Thiele, J., Vannucchi, A. M., & Tefferi, A. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.64 · Cited by 126 · see citing works
Self-citationFalini, B., Macijewski, K., Weiss, T., Bacher, U., Schnittger, S., Kern, W., Kohlmann, A., Klein, H., Vignetti, M., Piciocchi, A., et al. (2010) · Blood · doi:10.1182/blood-2009-08-240457 · Cited by 124 · see citing works
Germing, U., Lauseker, M., Hildebrandt, B., Symeonidis, A. S., Čermák, J., Fenaux, P., Kelaïdi, C., Pfeilstöcker, M., Nösslinger, T., Sekeres, M. A., et al. (2012) · Leukemia · doi:10.1038/leu.2011.391 · Cited by 124 · see citing works
Mallo, M., Cervera, J., Schanz, J., Such, E., Garcia‐Manero, G., Luño, E., Steidl, C., Espinet, B., Vallespı́, T., Germing, U., et al. (2010) · Leukemia · doi:10.1038/leu.2010.231 · Cited by 120 · see citing works
Molecular characterization ofde novoPhiladelphia chromosome-positive acute myeloid leukemia
Konoplev, S. N., Yin, C. C., Kornblau, S. M., Kantarjian, H. M., Konopleva, M. Y., Andreeff, M., Lu, G. G., Zuo, Z., Luthra, R., Medeiros, L. J., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.701739 · Cited by 117 · see citing works
DePersia, A., Godley, L. A., & Churpek, J. E. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12346 · Cited by 111 · see citing works
Neumann, M., Coskun, E., Fransecky, L. R., Mochmann, L. H., Bartram, I., Sartangi, N. F., Heesch, S., Gökbuget, N., Schwartz, S., Brandts, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053190 · Cited by 108 · see citing works
Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification
Hasserjian, R. P., Zuo, Z., Garcia, C. A., Tang, G., Kasyan, A., Luthra, R., Abruzzo, L. V., Kantarjian, H. M., Medeiros, L. J., & Wang, S. A. (2009) · Blood · doi:10.1182/blood-2009-09-243964 · Cited by 108 · see citing works
Self-citationClinical and genetic predictors of prognosis in myelodysplastic syndromes
Bejar, R. L. (2014) · Haematologica · doi:10.3324/haematol.2013.085217 · Cited by 102 · see citing works
Mughal, T. I., Cross, N. C. P., Padron, E., Tiu, R. V., Savona, M. R., Malcovati, L., Tibes, R., Komrokji, R. S., Kiladjian, J., Garcia-Manero, G., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.114660 · Cited by 100 · see citing works
Self-citationMühlbacher, V., Zenger, M., Schnittger, S., Weißmann, S., Kunze, F., Kohlmann, A., Bellos, F., Kern, W., Haferlach, T., & Haferlach, C. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22163 · Cited by 97 · see citing works
Barosi, G., Rosti, V., Bonetti, E., Campanelli, R., Carolei, A., Catarsi, P., Isgrò, A. M., Lupo, L., Massa, M., Poletto, V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035631 · Cited by 96 · see citing works
Meijerink, J. P. P. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.08.002 · Cited by 92 · see citing works
Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors
Parmentier, S., Schetelig, J., Lorenz, K., Krämer, M., Ireland, R. M., Schuler, U. S., Ordemann, R., Rall, G., Schaich, M. A., Bornhäuser, M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.056879 · Cited by 91 · see citing works
Germing, U., Strupp, C., Giagounidis, A. A. N., Haas, R. R., Gattermann, N., Starke, C., & Aul, C. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.02.014 · Cited by 90 · see citing works
Boer, J. M., Marchante, J. R. M., We, E., Horstmann, M. A., Escherich, G., Pieters, R., & den Boer, M. L. (2015) · Haematologica · doi:10.3324/haematol.2015.124941 · Cited by 89 · see citing works
Boiocchi, L., Espinal-Witter, R., Geyer, J. T., Steinhilber, J., Bonzheim, I., Knowles, D. M., Fend, F., & Orazi, A. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.165 · Cited by 87 · see citing works
Self-citationSchuler, E., Schroeder, M., Neukirchen, J., Strupp, C., Xicoy, B., Kündgen, A., Hildebrandt, B., Haas, R. R., Gattermann, N., & Germing, U. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.09.003 · Cited by 86 · see citing works
Mallo, M., Rey, M. D., Ibáñez, M., Calasanz, M. J., Arenillas, L., Larráyoz, M. J., Pedro, C., Jerez, A., Maciejewski, J. P., Costa, D., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12354 · Cited by 85 · see citing works
Bain, B. J., & Ahmad, S. (2014) · British Journal of Haematology · doi:10.1111/bjh.12963 · Cited by 84 · see citing works
Font, P., Loscertales, J., Benavente, C., Bermejo, A., Callejas, M., Garcia-Alonso, L., Garcia-Marcilla, A., Gil, S., López‐Rubio, M., Martin, E., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1565-4 · Cited by 83 · see citing works
Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes
Senent, L., Arenillas, L., Luño, E., Ruíz, J. C., Sanz, G. F., & Florensa, L. (2012) · Haematologica · doi:10.3324/haematol.2012.071449 · Cited by 82 · see citing works
Patnaik, M. M., Hanson, C. A., Sulai, N. H., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Lasho, T. L., & Tefferi, A. (2012) · Blood · doi:10.1182/blood-2012-03-415356 · Cited by 79 · see citing works
Does BCR / ABL 1 positive Acute Myeloid Leukaemia Exist?
Nacheva, E. P., Grace, C. D., Brazma, D., Gancheva, K., Howard‐Reeves, J., Rai, L. J., Gale, R. E., Linch, D. C., Hills, R. K., Russell, N. H., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12301 · Cited by 79 · see citing works
Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome
Roy, A., Roberts, I. A. G., & Vyas, P. (2012) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2012.02.010 · Cited by 74 · see citing works
Hollink, I. H. I. M., van den Heuvel‐Eibrink, M. M., Arentsen-Peters, S. T. C. J. M., Zimmermann, M., Peeters, J. K., Valk, P. J. M., Balgobind, B. V., Sonneveld, E., Kaspers, G. J. L., de Bont, E. S. J. M., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.031336 · Cited by 74 · see citing works
Grossmann, V., Bacher, U., Haferlach, C., Schnittger, S., Poetzinger, F., Weißmann, S., Roller, A., Eder, C., Fasan, A., Zenger, M., et al. (2013) · Leukemia · doi:10.1038/leu.2013.144 · Cited by 73 · see citing works
Chronic Myelogenous Leukemia, Version 1.2015
O’Brien, S., Radich, J. P., Abboud, C. N., Akhtari, M., Altman, J. K., Berman, E., Curtin, P. T., DeAngelo, D. J., Deininger, M. W., Devine, S. M., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0159 · Cited by 71 · see citing works
Indolent T-Lymphoblastic Proliferation (iT-LBP)
Ohgami, R. S., Arber, D. A., Zehnder, J. L., Natkunam, Y., & Warnke, R. A. (2013) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31828d17ec · Cited by 66 · see citing works
Self-citationVerburgh, E. R., Achten, R., Louw, V. J., Brusselmans, C., Delforge, M., Boogaerts, M. A., Hagemeijer, A., Vandenberghe, P., & Verhoef, G. E. G. (2007) · Leukemia · doi:10.1038/sj.leu.2404564 · Cited by 66 · see citing works
Bacher, U., Schnittger, S., Macijewski, K., Großmann, V., Kohlmann, A., Alpermann, T., Kowarsch, A., Nadarajah, N., Kern, W., Haferlach, C., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395574 · Cited by 65 · see citing works
Gisslinger, H., Jeryczynski, G., Gisslinger, B., Wölfler, A., Burgstaller, S., Buxhofer‐Ausch, V., Schalling, M., Krauth, M.-T., Schiefer, A.-I., Kornauth, C., et al. (2015) · Leukemia · doi:10.1038/leu.2015.360 · Cited by 63 · see citing works
Self-citationAcute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification
van den Ancker, W., Terwijn, M., Westers, T. M., Merle, P. A., van Beckhoven, E., Dräger, A. M., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2010) · Leukemia · doi:10.1038/leu.2010.119 · Cited by 62 · see citing works
Philadelphia chromosome‐positive mixed phenotype acute leukemia in the imatinib era
Shimizu, H., Yokohama, A., Hatsumi, N., Takada, S., Handa, H., Sakura, T., & Nojima, Y. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12343 · Cited by 62 · see citing works
Gianelli, U., Bossi, A., Cortinovis, I., Sabattini, E., Tripodo, C., Boveri, E., Moro, A., Valli, R., Ponzoni, M., Florena, A. M., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.196 · Cited by 61 · see citing works
Madelung, A. B., Bondo, H., Stamp, I. M., Loevgreen, P., Nielsen, S. L., Lauritzen, A. M. F., Knudsen, H., Ehinger, M., Dahl‐Sørensen, R. B., Mortensen, N. B., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23554 · Cited by 60 · see citing works
Self-citationEfficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
Rumi, E., Feenstra, J. D. M., Selleslag, D., Casetti, I. C., Lierman, E., Pietra, D., Cavalloni, C., Bellini, M., Milanesi, C., Dambruoso, I., et al. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2451-7 · Cited by 60 · see citing works
Self-citationAcute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics
Wang, S. A., & Hasserjian, R. P. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcprkyat6ezqhc7 · Cited by 52 · see citing works
Self-citationPatterer, V., Schnittger, S., Kern, W., Haferlach, T., & Haferlach, C. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1695-3 · Cited by 51 · see citing works
Myeloproliferative neoplasms: Morphology and clinical practice
Barbui, T., Thiele, J., Vannucchi, A. M., & Tefferi, A. (2015) · American Journal of Hematology · doi:10.1002/ajh.24288 · Cited by 50 · see citing works
Self-citationDiagnosis and management of mastocytosis: an emerging challenge in applied hematology
Valent, P. (2015) · Hematology · doi:10.1182/asheducation-2015.1.98 · Cited by 48 · see citing works
Díaz‐Beyá, M., Rozman, M., Pratcorona, M., Torrebadell, M., Camós, M., Aguilar, J. L., & Esteve, J. (2010) · Blood · doi:10.1182/blood-2010-09-307314 · Cited by 46 · see citing works
Cervera, N., Itzykson, R., Coppin, E., Prébet, T., Murati, A., Legall, S., Vey, N., Solary, É., Birnbaum, D., & Gelsi‐Boyer, V. (2014) · American Journal of Hematology · doi:10.1002/ajh.23702 · Cited by 44 · see citing works
MAASSEN, A. P., Strupp, C., Giagounidis, A. A. N., Kuendgen, A., Nachtkamp, K., Hildebrandt, B., Gattermann, N., Aul, C., Haas, R. R., & Germing, U. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.09.021 · Cited by 44 · see citing works
Hou, H.-A., Lin, L., Chen, C.-Y., & Tien, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605207 · Cited by 34 · see citing works
Boiocchi, L., Gianelli, U., Iurlo, A., Fend, F., Bonzheim, I., Cattaneo, D., Knowles, D. M., & Orazi, A. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.100 · Cited by 32 · see citing works
Self-citationA new prognostic score for CLL
Tam, C. S. L., & Seymour, J. F. (2014) · Blood · doi:10.1182/blood-2014-05-575407 · Cited by 32 · see citing works
Zuo, Z., Medeiros, L. J., Chen, Z., Liu, D., Bueso-Ramos, C., Luthra, R., & Wang, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041485 · Cited by 30 · see citing works
on behalf of Grup Català de Citologia Hematològica and Spanish CETLAM Group (Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas), Rozman, M., Navarro, J., Arenillas, L., Aventin, A. M., Giménez, T., Alonso, E., Perea, G., Camós, M., Navarrete, M., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2100-6 · Cited by 29 · see citing works
Diagnosing and Managing Advanced Chronic Myeloid Leukemia
Deininger, M. W. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e381 · Cited by 28 · see citing works
CML—where do we stand in 2015?
Hehlmann, R. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2331-1 · Cited by 27 · see citing works
Rey, M. D., Benito, R., Fontanillo, C., Campos-Laborie, F. J., Janusz, K., Velasco-Hernández, T., Abáigar, M., Hernández‐Sánchez, M., Cuello, R., Borrego, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126555 · Cited by 23 · see citing works
Kawajiri, C., Tanaka, H., Hashimoto, S., Takeda, Y., Sakai, S., Takagi, T., Takeuchi, M., Ohwada, C., Sakaida, E., Shimizu, N., et al. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1531-0 · Cited by 22 · see citing works
Acute myeloid leukemia with expanded erythropoiesis
Porwit‐MacDonald, A., & Vardiman, J. (2011) · Haematologica · doi:10.3324/haematol.2011.050526 · Cited by 16 · see citing works
Self-citationChronic Myelomonocytic Leukemia
Maslak, P. G. (2004) · ASH Image Bank · doi:10.1182/ashimagebank-2004-101198 · Cited by 2 · see citing works
Flagged first, then by citations
3 of the 139 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Bain BJ, Ahmad S. Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities? Br J Haematol. 2014;166(6): 809-817.
- Konoplev S, Yin CC, Kornblau SM, et al. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma. 2013;54(1): 138-144.
- Nacheva EP, Grace CD, Brazma D, et al. Does BCR/ABL1 positive acute myeloid leukaemia exist? Br J Haematol. 2013;161(4):541-550.
Cited by
Sorted by citations
Döhner, H., Estey, E. H., Grimwade, D. J., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., et al. (2016) · Blood · doi:10.1182/blood-2016-08-733196 · Cited by 5,776 · see citing works
Self-citationWHO classification of haematolymphoid tumours
Gaillard, F., & Gerstenmaier, J. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,763 · see citing works
Döhner, H., Wei, A. H., Appelbaum, F. R., Craddock, C., Dinardo, C. D., Dombret, H., Ebert, B. L., Fenaux, P., Godley, L. A., Hasserjian, R. P., et al. (2022) · Blood · doi:10.1182/blood.2022016867 · Cited by 3,341 · see citing works
Self-citationArber, D. A., Orazi, A., Hasserjian, R. P., Borowitz, M. J., Calvo, K. R., Kvasnicka, H.-M., Wang, S. A., Bagg, A., Barbui, T., Branford, S., et al. (2022) · Blood · doi:10.1182/blood.2022015850 · Cited by 2,945 · see citing works
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A. E., ELIAS, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,607 · see citing works
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0776-2 · Cited by 1,547 · see citing works
Functional genomic landscape of acute myeloid leukaemia
Tyner, J. W., Tognon, C. E., Bottomly, D., Wilmot, B., Kurtz, S. E., Savage, S. L., Long, N., Schultz, A. R., Traer, E. A., Abel, M. L., et al. (2018) · Nature · doi:10.1038/s41586-018-0623-z · Cited by 1,330 · see citing works
‘Acute myeloid leukemia: a comprehensive review and 2016 update’
de Kouchkovsky, I., & Abdul‐Hay, M. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.50 · Cited by 1,326 · see citing works
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
Terwilliger, T., & Abdul‐Hay, M. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.53 · Cited by 1,296 · see citing works
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
Beck, D. B., Ferrada, M. A., Sikora, K. A., Ombrello, A. K., Collins, J. C., Pei, W., Balanda, N. J., Ross, D. L., Cardona, D. O., Wu, Z., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026834 · Cited by 1,199 · see citing works
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Daver, N. G., Schlenk, R. F., Russell, N. H., & Levis, M. J. (2019) · Leukemia · doi:10.1038/s41375-018-0357-9 · Cited by 1,098 · see citing works
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Shallis, R. M., Wang, R., Davidoff, A. J., Ma, X., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.005 · Cited by 949 · see citing works
Prediction of acute myeloid leukaemia risk in healthy individuals
Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0317-6 · Cited by 850 · see citing works
Short, N. J., Rytting, M., & Cortes, J. E. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31041-9 · Cited by 815 · see citing works
Malard, F., & Mohty, M. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33018-1 · Cited by 795 · see citing works
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
Lindsley, R. C., Saber, W., Mar, B. G., Redd, R., Wang, T., Haagenson, M. D., Grauman, P. V., Hu, Z.-H., Spellman, S. R., Lee, S. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611604 · Cited by 776 · see citing works
Wei, A. H., Montesinos, P., Ivanov, V., Dinardo, C. D., Novák, J., Laribi, K., Kim, I., Stevens, D. A., Fiedler, W., Pagoni, M. N., et al. (2020) · Blood · doi:10.1182/blood.2020004856 · Cited by 763 · see citing works
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Chen, X., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 753 · see citing works
“The European Society of Rheumatology (EULAR) in 2019 equated the application of JAK inhibitors with that of biological DMARDs (bDMARDs) in circumstances where conventional synthetic DMARDs (csDMARDs) are ineffective.192–194 A large observational study of the efficacy of commonly used second-line RA drugs confirmed tha…”
MethodPediatric acute lymphoblastic leukemia
Inaba, H., & Mullighan, C. G. (2020) · Haematologica · doi:10.3324/haematol.2020.247031 · Cited by 710 · see citing works
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Sperling, A. S., Gibson, C. J., & Ebert, B. L. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.112 · Cited by 676 · see citing works
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Valent, P., Akin, C., & Metcalfe, D. D. (2016) · Blood · doi:10.1182/blood-2016-09-731893 · Cited by 680 · see citing works
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
Vainchenker, W., & Královics, R. (2016) · Blood · doi:10.1182/blood-2016-10-695940 · Cited by 673 · see citing works
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
O'Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., Bhatt, V. R., Bixby, D. L., Blum, W. G., Coutre, S. E., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0116 · Cited by 654 · see citing works
Self-citationBarbui, T., Thiele, J., Gisslinger, H., Kvasnicka, H. M., Vannucchi, A. M., Guglielmelli, P., Orazi, A., & Tefferi, A. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0054-y · Cited by 644 · see citing works
Self-citationClassification and Personalized Prognosis in Myeloproliferative Neoplasms
Grinfeld, J., Nangalia, J., Baxter, E. J., Wedge, D. C., Angelopoulos, N., Cantrill, R., Godfrey, A. L., Papaemmanuil, E., Gundem, G., MacLean, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716614 · Cited by 630 · see citing works
Barbui, T., Tefferi, A., Vannucchi, A. M., Passamonti, F., Silver, R. T., Hoffman, R., Verstovšek, S., Mesa, R. A., Kiladjian, J., Hehlmann, R., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0077-1 · Cited by 574 · see citing works
Genetic Basis of Acute Lymphoblastic Leukemia
Iacobucci, I., & Mullighan, C. G. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.7836 · Cited by 560 · see citing works
Guglielmelli, P., Lasho, T. L., Rotunno, G., Mudireddy, M., Mannarelli, C., Nicolosi, M., Pacilli, A., Pardanani, A. D., Rumi, E., Rosti, V., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.4886 · Cited by 553 · see citing works
Self-citationLuspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia‐Manero, G., Buckstein, R. J., Santini, V., Díez‐Campelo, M., Finelli, C., Cazzola, M., İlhan, O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1908892 · Cited by 551 · see citing works
Self-citationGenomics of Acute Myeloid Leukemia Diagnosis and Pathways
Bullinger, L., Döhner, K., & Döhner, H. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.2208 · Cited by 544 · see citing works
Passamonti, F., Cattaneo, C. M., Arcaini, L., Bruna, R., Cavo, M., Merli, F., Angelucci, E., Krampera, M., Cairoli, R., Porta, M. G. D., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30251-9 · Cited by 545 · see citing works
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
Metzeler, K. H., Herold, T., Rothenberg-Thurley, M., Amler, S., Sauerland, M. C., Görlich, D., Schneider, S., Konstandin, N. P., Dufour, A., Bräundl, K., et al. (2016) · Blood · doi:10.1182/blood-2016-01-693879 · Cited by 529 · see citing works
Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia
Granja, J. M., Klemm, S., McGinnis, L. M., Kathiria, A. S., Mezger, A., Corces, M. R., Parks, B., Gars, E., Liedtke, M., Zheng, G. X. Y., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0332-7 · Cited by 498 · see citing works
Cazzola, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1904794 · Cited by 496 · see citing works
Self-citationBone marrow niches in haematological malignancies
Méndez‐Ferrer, S., Bonnet, D. A., Steensma, D. P., Hasserjian, R. P., Ghobrial, I. M., Gribben, J. G., Andreeff, M., & Krause, D. S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0245-2 · Cited by 486 · see citing works
Self-citationClinical significance of somatic mutation in unexplained blood cytopenia
Malcovati, L., Gallì, A., Travaglino, E., Ambaglio, I., Rizzo, E., Molteni, E., Elena, C., Ferretti, V. V., Catricalà, S., Bono, E. B., et al. (2017) · Blood · doi:10.1182/blood-2017-01-763425 · Cited by 476 · see citing works
Self-citationHoelzer, D. T., Bassan, R., Dombret, H., Fielding, A. K., Ribera, J., & Buske, C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw025 · Cited by 465 · see citing works
Integrative detection and analysis of structural variation in cancer genomes
Dixon, J. R., Xu, J., Dileep, V., Zhan, Y., Song, F., Le, V. T., Yardımcı, G. G., Chakraborty, A., Bann, D. V., Wang, Y., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0195-8 · Cited by 452 · see citing works
Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
Shimony, S. O., Stahl, M. F., & Stone, R. M. (2023) · American Journal of Hematology · doi:10.1002/ajh.26822 · Cited by 474 · see citing works
“in the bone marrow or peripheral blood, any evidence of extramedullary myeloblasts (myeloid sarcoma), or presence of AML defining genetic abnormalities PML::RARA, RUNX1::RUNX1T1, and CBFB:: MYH11 irrespective of blast percentage.(42) Of note, Acute promyelocytic leukemia (APL), usually associated with a PML::RARA tran…”
BackgroundAdvances in acute myeloid leukemia
Newell, L. F., & Cook, R. J. (2021) · BMJ · doi:10.1136/bmj.n2026 · Cited by 455 · see citing works
Dinardo, C. D., Erba, H. P., Freeman, S. D., & Wei, A. H. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00108-3 · Cited by 463 · see citing works
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Bowman, R. L., Busque, L., & Levine, R. L. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.01.011 · Cited by 448 · see citing works
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Pemmaraju, N., Lane, A. A., Sweet, K. L., Stein, A. S., Vasu, S., Blum, W. G., Rizzieri, D. A., Wang, E. S., Duvic, M. A., Sloan, J. M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1815105 · Cited by 442 · see citing works
Global burden of hematologic malignancies and evolution patterns over the past 30 years
Zhang, N., Wu, J., Wang, Q., Liang, Y., Li, X., Chen, G., Ma, L., Liu, X., & Zhou, F. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00853-3 · Cited by 457 · see citing works
for the COMFORT-I investigators, Verstovšek, S., Mesa, R. A., Gotlib, J. R., Gupta, V. K., DiPersio, J. F., Catalano, J. V., Deininger, M. W., Miller, C. B., Silver, R. T., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0417-z · Cited by 433 · see citing works
Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations
Loh, P.-R., Genovese, G., Handsaker, R. E., Finucane, H. K., Reshef, Y. A., Palamara, P. F., Birmann, B. M., Talkowski, M. E., Bakhoum, S. F., McCarroll, S. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0321-x · Cited by 423 · see citing works
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Kang, J., Brajanovski, N., Chan, K. T., Xuan, J., Pearson, R. B., & Sanij, E. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00728-8 · Cited by 412 · see citing works
“The disease is characterized by erythroid hypoplasia, macrocytic anemia, hypolobated megakaryocytes with <5% bone marrow myeloblasts, <1% circulating peripheral blasts and absence of Auer rods as well as the presence of chromosome 5q deletion.(146) Haploinsufficiency of the genes located in two distinct commonly delet…”
BackgroundMLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
Winters, A. C., & Bernt, K. M. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00004 · Cited by 402 · see citing works
Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia
Bottomly, D., Long, N., Schultz, A. R., Kurtz, S. E., Tognon, C. E., Johnson, K., Abel, M., Agarwal, A., Avaylon, S., Benton, E., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.002 · Cited by 403 · see citing works
de Witte, T., Bowen, D., Robin, M., Malcovati, L., Niederwieser, D. W., Yakoub‐Agha, I., Mufti, G. J., Fenaux, P., Sanz, G. F., Martino, R., et al. (2017) · Blood · doi:10.1182/blood-2016-06-724500 · Cited by 383 · see citing works
Unravelling biology and shifting paradigms in cancer with single-cell sequencing
Baslan, T., & Hicks, J. B. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.58 · Cited by 377 · see citing works
van der Meij, K. R. M., Sistermans, E. A., Macville, M. V. E., Stevens, S. J. C., Bax, C. J., Bekker, M. N., Bilardo, C. M., Boon, E. M. J., Boter, M., Diderich, K. E. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.10.005 · Cited by 372 · see citing works
Acute myeloid leukemia: 2019 update on risk‐stratification and management
Estey, E. H. (2018) · American Journal of Hematology · doi:10.1002/ajh.25214 · Cited by 373 · see citing works
Ogawa, S. (2019) · Blood · doi:10.1182/blood-2018-10-844621 · Cited by 366 · see citing works
The genetic basis and cell of origin of mixed phenotype acute leukaemia
Alexander, T., Gu, Z., Iacobucci, I., Dickerson, K. M., Choi, J. K., Xu, B., Payne-Turner, D., Yoshihara, H., Loh, M. L., Horan, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0436-0 · Cited by 360 · see citing works
Self-citationElena, C., Gallì, A., Such, E., Meggendorfer, M., Germing, U., Rizzo, E., Cervera, J., Molteni, E., Fasan, A., Schuler, E., et al. (2016) · Blood · doi:10.1182/blood-2016-05-714030 · Cited by 364 · see citing works
Self-citationLambert, J., Pautas, C., Terré, C., Raffoux, E., Turlure, P., Caillot, D., Legrand, O., Thomas, X., Gardin, C., Gogat, K., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.188888 · Cited by 362 · see citing works
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
Bluteau, O., Sébert, M., Leblanc, T. M., de Latour, R. P., Quentin, S., Lainey, É., Hernandez, L., Dalle, J., de Fontbrune, F. S., Lengliné, É., et al. (2017) · Blood · doi:10.1182/blood-2017-09-806489 · Cited by 352 · see citing works
Tefferi, A., & Barbui, T. (2020) · American Journal of Hematology · doi:10.1002/ajh.26008 · Cited by 365 · see citing works
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
Vetrie, D. L. P., Helgason, G. V., & Copland, M. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-019-0230-9 · Cited by 351 · see citing works
Isocitrate dehydrogenase mutations in myeloid malignancies
Medeiros, B. C., Fathi, A. T., Dinardo, C. D., Pollyea, D. A., Chan, S. M., & Swords, R. T. (2016) · Leukemia · doi:10.1038/leu.2016.275 · Cited by 348 · see citing works
The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
Nepstad, I., Hatfield, K. J., Grønningsæter, I. S., & Reikvam, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082907 · Cited by 350 · see citing works
Passamonti, F., Toni Giorgino, A., Mora, B., Guglielmelli, P., Rumi, E., Maffioli, M., Rambaldi, A., Caramella, M., Komrokji, R. S., Gotlib, J. R., et al. (2017) · Leukemia · doi:10.1038/leu.2017.169 · Cited by 352 · see citing works
Self-citationFrom Erythroblasts to Mature Red Blood Cells: Organelle Clearance in Mammals
Moras, M., Lefevre, S. D., & Ostuni, M. A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01076 · Cited by 343 · see citing works
Bosch de Basea, M., Thierry-Chef, I., Harbron, R., Hauptmann, M., Byrnes, G., Bernier, M.-O., Le Cornet, L., Dabin, J., Ferro, G., Istad, T. S., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02620-0 · Cited by 349 · see citing works
“…to cell lineage and maturation 27,28 , the analyses were conducted using the revised WHO classification of lymphoid and myeloid malignancies 27,28 , focusing on the following groupings, types and subtypes (morphology codes in Supplementary Table 1): • All hematological malignancies,…”
InfluentialChronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hochhaus, A., Saußele, S., Rosti, G., Mahon, F., Janssen, J. J. W. M., Hjorth‐Hansen, H., Richter, J., & Buske, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx219 · Cited by 342 · see citing works
for the European Society for Blood and Marrow Transplantation (EBMT), Duarte, R. F., Labopin, M., Bader, P., Basak, G. W., Bonini, C., Chabannon, C., Corbacioglu, S., Dreger, P., Dufour, C., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0516-2 · Cited by 343 · see citing works
Krauss, A. C., Gao, X., Li, L., Manning, M. L., Patel, P., Fu, W., Janoria, K. G., Gieser, G., Bateman, D. A., Przepiorka, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2990 · Cited by 336 · see citing works
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021
Pollyea, D. A., Altman, J. K., Assi, R. E., Bachiashvili, K., Bhatt, V. R., Fathi, A. T., Fedorov, K., Foran, J. M., Gojo, I., Goldberg, A., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0002 · Cited by 326 · see citing works
Eosinophils from Physiology to Disease: A Comprehensive Review
Ramirez, G. A., Yacoub, M., Ripa, M., Mannina, D., Cariddi, A., Saporiti, N., Ciceri, F., Castagna, A., Colombo, G., & Dagna, L. (2018) · BioMed Research International · doi:10.1155/2018/9095275 · Cited by 320 · see citing works
Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management
Tefferi, A. (2020) · American Journal of Hematology · doi:10.1002/ajh.26050 · Cited by 316 · see citing works
Towards precision medicine for AML
Döhner, H., Wei, A. H., & Löwenberg, B. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00509-w · Cited by 314 · see citing works
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis
Tefferi, A., Guglielmelli, P., Nicolosi, M., Mannelli, F., Mudireddy, M., Bartalucci, N., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0107-z · Cited by 308 · see citing works
Molecular biomarkers in acute myeloid leukemia
Prada‐Arismendy, J., Arroyave-Ospina, J. C., & Röthlisberger, S. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.08.005 · Cited by 303 · see citing works
Dong, W., Wu, X., Ma, S., Wang, Y., Nalin, A. P., Zhu, Z. G., Zhang, J., Benson, D. M., He, K., Caligiuri, M. A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1259 · Cited by 301 · see citing works
Aberrant RNA Splicing in Cancer
Escobar‐Hoyos, L. F., Knorr, K. L. B., & Abdel-Wahab, O. I. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050407 · Cited by 300 · see citing works
Philadelphia chromosome–like acute lymphoblastic leukemia
Tasian, S. K., Loh, M. L., & Hunger, S. P. (2017) · Blood · doi:10.1182/blood-2017-06-743252 · Cited by 299 · see citing works
Malcovati, L., Stevenson, K. E., Papaemmanuil, E., Neuberg, D. S., Bejar, R. L., Boultwood, J., Bowen, D., Campbell, P. J., Ebert, B. L., Fenaux, P., et al. (2020) · Blood · doi:10.1182/blood.2020004850 · Cited by 298 · see citing works
Self-citationGenome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers
Duncavage, E. J., Schroeder, M. C., O’Laughlin, M., Wilson, R., MacMillan, S., Bohannon, A. S., Kruchowski, S. S., Garza, J. E., Du, F., Hughes, A. E. O., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2024534 · Cited by 293 · see citing works
Platzbecker, U., Germing, U., Götze, K. S., Kiewe, P., Mayer, K., Chromik, J., Radsak, M., Wolff, T., Zhang, X., Laadem, A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30615-0 · Cited by 292 · see citing works
Kanate, A. S., Majhail, N. S., Savani, B. N., Bredeson, C., Champlin, R. E., Crawford, S. W., Giralt, S. A., LeMaistre, C. F., Marks, D. I., Omel, J. L., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.03.002 · Cited by 285 · see citing works
Life histories of myeloproliferative neoplasms inferred from phylogenies
Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A., Godfrey, A. L., Green, A. R., et al. (2022) · Nature · doi:10.1038/s41586-021-04312-6 · Cited by 285 · see citing works
Barbui, T., Vannucchi, A. M., Buxhofer‐Ausch, V., Stefano, V. D., Betti, S., Rambaldi, A., Rumi, E., Ruggeri, M., Rodeghiero, F., Randi, M. L., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.94 · Cited by 284 · see citing works
Self-citationHuman-level recognition of blast cells in acute myeloid leukaemia with convolutional neural networks
Matek, C., Schwarz, S., Spiekermann, K., & Marr, C. (2019) · Nature Machine Intelligence · doi:10.1038/s42256-019-0101-9 · Cited by 289 · see citing works
Maus, M. V., Alexander, S., Bishop, M. R., Brudno, J. N., Callahan, C. A., Davila, M. L., Diamonte, C., Dietrich, J., Fitzgerald, J. C., Frigault, M. J., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001511 · Cited by 282 · see citing works
Heuser, M., Ofran, Y., Boissel, N., Brunet, S., Craddock, C., Janssen, J. J. W. M., Wierzbowska, A., & Buske, C. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.018 · Cited by 286 · see citing works
Myeloid neoplasms with eosinophilia
Reiter, A., & Gotlib, J. R. (2016) · Blood · doi:10.1182/blood-2016-10-695973 · Cited by 282 · see citing works
Age-related clonal hematopoiesis
Shlush, L. I. (2018) · Blood · doi:10.1182/blood-2017-07-746453 · Cited by 281 · see citing works
Adult Acute Lymphoblastic Leukemia
Paul, S., Kantarjian, H. M., & Jabbour, E. J. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.09.010 · Cited by 282 · see citing works
Miller, D. T., Lee, K., Abul‐Husn, N. S., Amendola, L. M., Brothers, K. B., Chung, W. K., Gollob, M. H., GORDON, A. S., Harrison, S. M., Hershberger, R. E., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.04.006 · Cited by 277 · see citing works
Verstovsek, S., Gotlib, J., Mesa, R. A., Vannucchi, A. M., Kiladjian, J.-J., Cervantes, F., Harrison, C. N., Paquette, R., Sun, W., Naim, A., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0527-7 · Cited by 305 · see citing works
Nucleophosmin: from structure and function to disease development
Box, J. K., Paquet, N., Adams, M. N., Boucher, D., Bolderson, E., O'Byrne, K. J., & Richard, D. J. (2016) · BMC Molecular Biology · doi:10.1186/s12867-016-0073-9 · Cited by 272 · see citing works
Mutations in AML: prognostic and therapeutic implications
Dinardo, C. D., & Cortes, J. E. (2016) · Hematology · doi:10.1182/asheducation-2016.1.348 · Cited by 267 · see citing works
Passamonti, F., Grießhammer, M., Palandri, F., Egyed, M., Benevolo, G., Devos, T., Callum, J., Vannucchi, A. M., Şıvgın, S., Bensasson, C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30558-7 · Cited by 260 · see citing works
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Rumi, E., & Cazzola, M. (2016) · Blood · doi:10.1182/blood-2016-10-695957 · Cited by 263 · see citing works
Self-citationDiagnosis and Treatment of Myelodysplastic Syndromes
Sekeres, M. A., & Taylor, J. (2022) · JAMA · doi:10.1001/jama.2022.14578 · Cited by 262 · see citing works
Diagnosis and classification of hematologic malignancies on the basis of genetics
Taylor, J., Xiao, W., & Abdel-Wahab, O. I. (2017) · Blood · doi:10.1182/blood-2017-02-734541 · Cited by 251 · see citing works
Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
Liu, Y., Cheng, Z., Pang, Y., Cui, L., Qian, T., Quan, L., Zhao, H., Shi, J., Ke, X., & Fu, L. N. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0734-5 · Cited by 246 · see citing works
Valent, P., Akin, C., Hartmann, K., Nilsson, G. P., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T. I., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2234 · Cited by 247 · see citing works
Self-citationBaliakas, P., Jeromin, S., Iskas, M., Puiggros, A., Plevová, K., Nguyen‐Khac, F., Davis, Z. A., Rigolin, G. M., Visentin, A., Xochelli, A., et al. (2019) · Blood · doi:10.1182/blood-2018-09-873083 · Cited by 242 · see citing works
- Authors
- Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W.
- Affiliations
- Stanford Medicine (US)
- Weill Cornell Medicine (US)
- Massachusetts General Hospital (US)
- University of Cologne (DE)
- Johns Hopkins Medicine (US)
- Section of Hematology/Oncology, University of Chicago, Chicago, IL;
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- University of Pavia (IT)
- University of Chicago (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2016-05-19
- Volume
- 127
- Issue
- 20
- Pages
- 2391-2405
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2339658711
- Cited by
- 10,119
- References
- 139
- Citations by year
- 2026: 370 · 2025: 615 · 2024: 875 · 2023: 1132 · 2022: 1265 · 2021: 1424 · 2020: 1187 · 2019: 998 · 2018: 954 · 2017: 797 · 2016: 320 · 2015: 117 · 2014: 41 · 2013: 2
- FWCI
- 145.41
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-07-21)
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Funders
- Celgene
- Incyte
- Sysmex Corporation
- Genentech
- Takeda Oncology
- Pharmacyclics
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Keywords
- WHO classification of hematologic neoplasms, myeloid neoplasms, acute leukemia, diagnostic criteria, prognostic factors, gene expression profiling, next-generation sequencing, immunophenotyping, morphological classification, new disease entity
- MeSH terms
- Down Syndrome, Eosinophilia, Humans, Leukemia, Myeloid, Mastocytosis, Myelodysplastic Syndromes, Myeloproliferative Disorders, World Health Organization, Oncogene Proteins, Fusion, Cell Lineage, Myeloid Cells, Genes, Neoplasm, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
